A University of Toronto study is providing reassuring evidence about the consumption of soy foods in women* who are postmenopausal. The analysis of 40 randomized controlled trials in over 3,000 participants found that estrogen-like compounds in soy had no effect on key markers of estrogen-related cancers, supporting its safety as both a food and potential therapy.

In a new research paper published in MedComm-Oncology, the team of Yongsheng Li/Dairong Li/Huakan Zhao provided an effective and accurate ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) tool for the simultaneous detection of aumolertinib, osimertinib, gefitinib and their major metabolites, demonstrating the great bioavailability and tissue distribution characteristics of aumolertinib.

A multinational collaboration co-led by the Garvan Institute of Medical Research has uncovered a potential explanation for why some cancer patients receiving a type of immunotherapy called checkpoint inhibitors experience increased susceptibility to common infections.